About VERSATOPE THERAPEUTICS INC
Versatope Therapeutics is a clinical-stage biotechnology company that develops immuno-therapeutics using a proprietary platform based on Recombinant Extracellular Transport Vesicles (RET-Vs) to deliver cross-strain immunity for infectious diseases and cancer.
Design and production of Recombinant Extracellular Transport Vesicles (RET-Vs)Development of multi-strain vaccines using probiotic vesiclesDelivery of therapeutic RNA directly into cancer cellsRapid synthesis, scale-up, and distribution of vaccinesThermostable vaccine formulations
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 | Department of Health and Human Services | $16.8M | |
| Federal contract award | Department of Health and Human Services | $450K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VERSATOPE THERAPEUTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.